retatrutide ly3437943 parkinson's disease clinical trial The Phase 3 Exenatide results Retatrutide the wonder drug: What's

Retatrutide & Pemvidutide are a triple agonist, which means they act on GLP-1R, GIP-R, & glucagon receptors (GCGR)

Phentermine is not a GLP-1 drug

Very low body fat People with very low body fat percentages (typically below 10-12% for men or 18-20% for women) may not have sufficient subcutaneous tissue on the thigh for reliable subcutaneous injection

A network meta-analysis published recently confirmed this pattern, finding that retatrutide demonstrated greater absolute weight reduction compared to tirzepatide (retatrutide: MD -16.34 kg vs tirzepatide: MD -11.82 kg)

What GLP -1 do you prescribe

Light protection Semaglutide is sensitive to photodegradation